The World Health Organization (WHO) announced on Monday 25 May that as a precautionary measure, it had “temporarily” suspended the clinical trials on hydroxychloroquine carried out under the Solidarity programme.
This decision follows the publication of a study a few days earlier in the medical journal The Lancet. After analysing data from approximately 96,000 patients infected with Sars Cov-2, the Commission found the use of chloroquine or its derivatives, such as hydroxychloroquine,...